CBD Life Sciences Inc. (OTCMKTS:CBDL) Short Interest Up 235.4% in January

CBD Life Sciences Inc. (OTCMKTS:CBDL) was the recipient of a large increase in short interest in January. As of January 15th, there was short interest totalling 132,500 shares, an increase of 235.4% from the December 31st total of 39,500 shares. Based on an average trading volume of 41,884,600 shares, the short-interest ratio is currently 0.0 days.

CBD Life Sciences Price Performance

Shares of CBDL traded up $0.00 during mid-day trading on Thursday, hitting $0.00. 13,218,689 shares of the company’s stock were exchanged, compared to its average volume of 20,097,977. CBD Life Sciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.03.

About CBD Life Sciences

CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.